These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
234 related items for PubMed ID: 12269993
1. Immunohistochemical detection of hepatocyte growth factor, transforming growth factor-beta and their receptors in epithelial odontogenic tumors. Kumamoto H, Yoshida M, Ooya K. J Oral Pathol Med; 2002 Oct; 31(9):539-48. PubMed ID: 12269993 [Abstract] [Full Text] [Related]
2. Co-expression of hepatocyte growth factor and c-met in epithelial odontogenic tumors. Poomsawat S, Punyasingh J, Vejchapipat P, Larbcharoensub N. Acta Histochem; 2012 Jul; 114(4):400-5. PubMed ID: 21855117 [Abstract] [Full Text] [Related]
3. Expression of bone morphogenetic proteins and their associated molecules in ameloblastomas and adenomatoid odontogenic tumors. Kumamoto H, Ooya K. Oral Dis; 2006 Mar; 12(2):163-70. PubMed ID: 16476038 [Abstract] [Full Text] [Related]
7. Immunohistochemical detection of amelogenin and cytokeratin 19 in epithelial odontogenic tumors. Kumamoto H, Yoshida M, Ooya K. Oral Dis; 2001 May; 7(3):171-6. PubMed ID: 11495193 [Abstract] [Full Text] [Related]
8. Detection of mitochondria-mediated apoptosis signaling molecules in ameloblastomas. Kumamoto H, Ooya K. J Oral Pathol Med; 2005 Oct; 34(9):565-72. PubMed ID: 16138896 [Abstract] [Full Text] [Related]
9. Immunohistochemical detection of platelet-derived endothelial cell growth factor/thymidine phosphorylase and angiopoietins in ameloblastic tumors. Kumamoto H, Ooya K. J Oral Pathol Med; 2006 Nov; 35(10):606-12. PubMed ID: 17032393 [Abstract] [Full Text] [Related]
10. Association between vascular endothelial growth factor (VEGF) expression and tumor angiogenesis in ameloblastomas. Kumamoto H, Ohki K, Ooya K. J Oral Pathol Med; 2002 Jan; 31(1):28-34. PubMed ID: 11896820 [Abstract] [Full Text] [Related]
11. Expression of tumor necrosis factor alpha, TNF-related apoptosis-inducing ligand, and their associated molecules in ameloblastomas. Kumamoto H, Ooya K. J Oral Pathol Med; 2005 May; 34(5):287-94. PubMed ID: 15817072 [Abstract] [Full Text] [Related]
12. Immunohistochemical detection of phosphorylated JNK, p38 MAPK, and ERK5 in ameloblastic tumors. Kumamoto H, Ooya K. J Oral Pathol Med; 2007 Oct; 36(9):543-9. PubMed ID: 17850438 [Abstract] [Full Text] [Related]
13. p53 gene status and expression of p53, MDM2, and p14 proteins in ameloblastomas. Kumamoto H, Izutsu T, Ohki K, Takahashi N, Ooya K. J Oral Pathol Med; 2004 May; 33(5):292-9. PubMed ID: 15078490 [Abstract] [Full Text] [Related]
14. Immunohistochemical analysis of inducible nitric oxide synthase (iNOS) and heat shock proteins (HSPs) in ameloblastomas. Kumamoto H, Suzuki T, Ooya K. J Oral Pathol Med; 2002 Nov; 31(10):605-11. PubMed ID: 12406306 [Abstract] [Full Text] [Related]
15. Immunohistochemical detection of beta-catenin and adenomatous polyposis coli in ameloblastomas. Kumamoto H, Ooya K. J Oral Pathol Med; 2005 Aug; 34(7):401-6. PubMed ID: 16011608 [Abstract] [Full Text] [Related]
16. Immunohistochemical detection of BH3-only proteins in ameloblastic tumors. Kumamoto H, Ooya K. Oral Dis; 2008 Sep; 14(6):550-5. PubMed ID: 18826384 [Abstract] [Full Text] [Related]
17. K-Ras gene status and expression of Ras/mitogen-activated protein kinase (MAPK) signaling molecules in ameloblastomas. Kumamoto H, Takahashi N, Ooya K. J Oral Pathol Med; 2004 Jul; 33(6):360-7. PubMed ID: 15200485 [Abstract] [Full Text] [Related]